NCT01988376View on ClinicalTrials.gov

Comparing the Rate of Insufficient Cells for Diagnosis Between Surepath® and Conventional Smear in Women After Radiation Therapy for Cervical Cancer

NACompletedINTERVENTIONAL
Enrollment

258

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

November 30, 2014

Conditions
Cervical Cancer
Interventions
DEVICE

Surepath

A liquid-base method of Pap smear for screening the recurrence of cervical cancer

DEVICE

Conventional Pap smear

Conventional Pap smear

Trial Locations (1)

22050

Far Eastern Memorial Hospital, Banqiao District

All Listed Sponsors
collaborator

Gynecologic Oncology Group

NETWORK

lead

Far Eastern Memorial Hospital

OTHER

NCT01988376 - Comparing the Rate of Insufficient Cells for Diagnosis Between Surepath® and Conventional Smear in Women After Radiation Therapy for Cervical Cancer | Biotech Hunter | Biotech Hunter